Accéder au contenu
Merck

Sesamol attenuates oxidative stress-mediated experimental acute pancreatitis in rats.

Human & experimental toxicology (2011-11-15)
P-Y Chu, P Srinivasan, J-F Deng, M-Y Liu
RÉSUMÉ

Acute pancreatitis is a potentially fatal disease with no known cure. The initial events in acute pancreatitis may occur within the acinar cells. We examined the effect of sesamol on (i) a cerulein-induced pancreatic acinar cancer cell line, AR42J, and (ii) cerulein-induced experimental acute pancreatitis in rats. Sesamol inhibited amylase activity and increased cell survival. It also inhibited medium lipid peroxidation and 8-hydroxydeoxyguanosine in AR42J cells compared with the cerulein-alone groups. In addition, in cerulein-treated rats, sesamol inhibited serum amylase and lipase levels, pancreatic edema, and lipid peroxidation, but it increased pancreatic glutathione and nitric oxide levels. Thus, we hypothesize that sesamol attenuates cerulein-induced experimental acute pancreatitis by inhibiting the pancreatic acinar cell death associated with oxidative stress in rats.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Sesamol, 98%